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ABSTRACT: Understanding of enzyme reaction mechanism can lead to the design of enzyme inhibitors. A Claisen rear-
rangement was used to allow the conversion of an a-1,4 disaccharide into an a-1,3-linked glycosylcarbasugar to target the 
endo-a-mannosidase from glycosidase family GH99 which, unusually, is believed to act through a 1,2 anhydrosugar Òepox-
ideÓ intermediate. Using NMR and X-ray crystallography, it is shown that glucosylcarbasugar-a-aziridines can act as reason-
ably potent endo-a-mannosidase inhibitors, likely by virtue of their shape-mimicry and the interactions of the aziridine nitro-
gen with the conserved catalytic acid/base of the enzyme active-site. 
Understanding enzyme reaction mechanisms is essential for 
the rational design of inhibitors. Glycoside hydrolases 
(GH), also called glycosidases, are a vast group of enzymes 
that are classified, based upon their amino-acid sequence 
similarity, into over 150 distinct families in the Carbohy-
drate Active Enzymes database (CAZy).1,2 The vast majori-
ty of these enzymes can be divided into two classes accord-
ing to their reaction mechanism and the relative configura-
tion of substrate and product: those that act with retention 
or inversion of anomeric configuration. The retaining gly-
cosidases utilize a double nucleophilic displacement which 
results in net retention of configuration at the anomeric 
center. The retaining reaction classically involves nucleo-
philic amino-acid side-chain and proceeds via a covalent 
glycosyl-enzyme intermediate. Some enzymes also use 
neighboring group participation reactions (notably those 
active on beta linked GlcNAc).3 Recently, a new neigh-
bouring-group retaining mechanism involving an interme-
diate epoxide and hence no covalent bond to the enzyme 
was proposed for endo-a-mannosidases and endoman-
nanases (a-Glc-1,3-a-Man-OR and a-Man-1,3-a-Man-OR 
substrates) of the GH99 family.4,5 In this putative mecha-
nism, nucleophilic attack by the manno-O2 atom, allows 
catalysis via a 1,2 anhydro sugar ÒepoxideÓ intermediate. 
(Scheme 1). In terms of shape and charge changes, a posi-
tive charge is very likely to be developed and the confor-
mation of the pyranose changes from 4C1 of the substrate to 
the 4E/ 4H5 of the epoxide. Based on these considerations, 
inhibitors that have been designed for this important class 
of enzymes6 are a-1,3-disaccharide analogues and these 
fall into two categories: those which mimic the charge and 
those which mimic its shape. In the first class, we find the 
usual deoxymannojirimycin (1), isofagomine (2) or 
noeuromycin derivatives.4,7 A clear influence of the amine 
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 position has been demonstrated. It has also been shown that 
the glucal derivative 3 is an inhibitor of the enzyme due to 
its shape, which corresponds to a 4H5 conformation.
7 Here, 
we decided to combine both properties in a new inhibitor 
and create an amine with a likely 4E/ 4H5 conformation. To 
achieve both the half-chair conformation and introduce an 
amino group, we decided to synthesize an aziridine on a 
carbasugar for obvious stability reason. Furthermore, ac-
cording to the mechanism, the catalytic acid E336 of Bac-
teroides xylanisolvens GH99 (BxGH99) should be in its 
acidic form and therefore prone to release a proton to the 
aziridine, hence we decided to investigate the synthesis and 
inhibitory ability of glucosyl-carbasugar-a-aziridine 4. 
(Scheme 1) 
There are many ways to synthesize carbasugars,8 including 
those containing a disaccharide motif.9 The most direct way 
would be to start directly from the corresponding disaccha-
ride,
10
 but the necessary 1,3-disaccharides (like Glc-a-1,3-
Glc) are rare and expensive. The synthesis of the two mon-
osaccharides and their subsequent assembly seemed tedi-
ous. We therefore decided to use a trick based on the use of 
Claisen rearrangement to make carbasugars nicely devel-
oped by Nagarajan on monosaccharides.11 In this reaction, 
a glucal functionalized with an alkene in position 6 affords 
a carba-glucal with an aldehyde in position 6. This is due to 
the symmetry of the molecule, and in the operation, the 
protecting group in position 4 becomes the one in position 
3 in the new numbering of the carbasugar. (Scheme 2) 
This approach was used to synthesize a 1,3-pseudo-
disaccharide from a 1,4-disaccharide. The synthesis would 
start from maltose, that would be converted into the doubly 
unsaturated maltal 5, which in turn could undergo Claisen 
rearrangement to give keto-alkene 6. This operation is key 
to the total synthesis as we not only obtain the desired 1,3-
pseudo-disaccharide but also the alkene which will be con-
verted into the desired epoxide 7 and aziridine 4. (Scheme 
3) 
Scheme 2. Claisen rearrangement leading to interchange of 
position 3 and 4 from the glucal to the carba-glucal. 
 
 
Scheme 1. Postulated enzymatic hydrolytic mechanism for Bacteroides xylanisolvens GH99 (BxGH99), in which catalysis 
occurs through a 1,2 anhydrosugar intermediate (top). Known, and designed (this work) substrate analogues (below) Resi-
due numbering as in BxGH99. 
 
Scheme 3. Retrosynthetic analysis for the synthesis of aziridine 4.  
 
O
OBn
BnO
OBn
BnO
OBn
BnO
O
O
Claisen
rearrangement
1
23
4
56
7
1
2
3
4
5
6
7 1
23
4
56
5a
New numbering
Glucal derivative Carba-glucal derivative
HO
O
HO
OHO
O
O
HO O
OHO
HO
HO
HO
H
OR
HO
Glu336
O
O
Glu336
O
H
OH
HO
O
O
HO O
OHO
HO
HO
HO
H
OH
HO
Glu336
O
ROH
O
Glu333
O
OHO
HO
HO
HO
O
H
O
Glu333
O
O
Glu333
O
HO
OH
N
HOHO
HO
HO
HO
O
421
HO
NH
O
HO OH
OHO
HO
HO
HO
HO
NHO
HO
OHO
HO
HO
HO
HO
O
OH
OHO
HO
HO
HO
O
Charge mimicry Shape  mimicry Charge & Shape  mimicry
3
HO
OH
N
HOHO
HO
HO
HO
O
O O
PO
O
PO
OP
OP
POPO
O
O
PO
PO
PO
OP
O
PO
OP
O
PO
OP
PO
OP
O
O
O
O
HO
OH
OH
HO
O
HO
OH
OH
OH
Maltose
Claisen
 rearrangement
O O
PO
O
PO
OP
OP
PO
H
O
O
PO
O
PO
OP
OP
PO
Claisen
rearrangement
H
7
4
6
6
5
6
α-1,4-disaccharideα-1,3-pseudo-disaccharide
 Maltal was prepared according to Haworth,12 with a slight 
modification in the deprotection step (see SI). Next, the 
differentiation of the two primary hydroxyl groups was 
required. For this, we decided to protect the glucoside with 
a benzylidene group. This reaction had to be performed 
with great care (Scheme 4) by controlling the amount of 
camphor sulfonic acid used (0.1 equiv). Then, the other 
primary alcohol could be selectively silylated, subsequent 
benzylation and de-silylation afforded the alcohol 8. Oxida-
tion using Dess-Martin periodinane (DMP) followed by 
olefination produced dialkene 9. Claisen rearrangement on 
9 was performed under micro-wave irradiation at 240 ¡C 
and was immediately followed by the aldehyde reduction to 
afford alcohol 10 in 76% yield. (Scheme 4)
 
Scheme 4. Key Claisen rearrangement and preparation of the substrate 10. 
 
Scheme 5. Synthesis of aziridine carbasugars 4. 
 
 
With the alkene 10 in hand, we investigated its aziridina-
tion. We opted for a three-step route: epoxidation, azide-
ring opening, and Staudinger azide-reduction-
aziridination;13 this strategy also operates with overall 
inversion of configuration of the three-membered ring. 
We first benzylated the remaining hydroxyl in 10 to give 
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 11, which was epoxidized using me-
thyl(trifluoromethyl)dioxirane generated in situ14 to give 
the α-epoxide 12 in 46% yield and the β-epoxide 13 in 
26% yield, which were separated by silica gel flash chro-
matography. The stereochemistry of these epoxides was 
determined thanks to a NOESY experiment. α-Epoxide 12 
displayed cross correlations between H-5 and H-3, while 
in β-epoxide 13 H-5 showed cross-correlations with H-3 
but also with H-1 and H-2 (Scheme 5 and SI). This reac-
tion therefore produced the undesired α-epoxide as the 
major product, but all our attempts to improve the situa-
tion with various epoxidation reactions gave lower yields. 
For instance, mCPBA which was previously often used to 
synthesize epoxides from cyclohexenes polyols15 did not 
improve the selectivity nor the yield. Further treatment of 
the isolated epoxide 13 with sodium azide furnished a 
mixture of 1,2-trans azido alcohols 14/15, which under 
the action of PPh3 afforded α-aziridine 16 in 52% yield 
after these two steps. Final deprotection, using Birch 
conditions,16 afforded the unprotected aziridinated pseu-
do-sugar 4 (Scheme 5).  
 
The properties of aziridine 4 were investigated with 
GH99 family members Bt (Bacteorides thetaiotaomicron) 
and BxGH99. A crystal structure of the BxGH99 enzyme 
in complex with the aziridine 4 at a resolution of 1.27  
(PDB accession: 6HMG) was obtained by soaking of 
BxGH99 crystals with an aqueous solution of the com-
pound. The nitrogen atom of the aziridine makes a 2.6  
hydrogen bond with one of the side chain oxygen atoms 
of BxGH99 residue E336, which acts as an acid/base in 
the proposed GH99 mechanism (Scheme 1). In a ternary 
complex with the aziridine and α-1,2-mannobiose (ob-
tained at a resolution of 1.03 , PDB 6HMH), this dis-
tance changes to 2.7 . The interaction is shown in Figure 
1A. In both cases, the pseudopyranose ring is in a 4H5 
conformation, as predicted for the azirdine and likely 
resembles the intermediate/transition-state of the reaction. 
Indeed, it binds similarly to ManGlucal and GlcChex17 
(Figure 1B), which was also observed in a 4H5 confor-
mation in complex with BxGH99 (PDB 5M5D and 
5MC8).7 
Using NMR we have determined the dissociation constant 
(KD) of the aziridine with 
15N-labelled BtGH99 to be 11.5 
± 0.9 µM (Figure 1C). The compound, therefore, binds to 
BtGH99 with an affinity 2-fold higher than GlcDMJ 
(24 µM) and slightly higher than ManGlucal (15 µM). 
However, it is not a potent inhibitor in comparison with 
GlcIFG, ManIFG or ManNOE, all of which bind to 
BtGH99 with a KD in the nanomolar range.
7 
 
 
Figure 1. (A) Divergent stereo (Òwall-eyedÓ) view of 4 in complex with BxGH99. Catalytic residues surrounding the Ð1 sub-
site and the interaction between the aziridine N and E336 Oε are shown. The 2mFo-DFc synthesis contoured at 1 e
-/3. (B) 
Comparison of the ligands observed in the 4H5 conformation in complex with BxGH99.
7 Green: the aziridine 4, gold: Man-
Glucal (from PDB 5M5D), grey: GlcChex (from PDB 5MEL). The sugar moiety in the Ð2 subsite is not shown. (C) The re-
sult of NMR titration of BtGH99 with 4. The protein concentration in the solution was 58 µM. 
 
 In conclusion, we have devised a strategy to synthesize 
1,3-glycosyl-carbasugars designed to interact with the 
family GH99 endo-a-mannosidases. The obtained inhibi-
tor has improved activity in comparison with the shape 
mimics, but does not reach the affinity of isofagomine or 
noeuromycin analogues. This probably indicates that the 
aziridine is not charged owing to its lower pKa. In future 
work, we will be able to use this synthetic strategy to 
synthesize other analogues to study the mechanism of this 
family of glycosidases which is not yet firmly established. 
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